NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 270 filers reported holding NOVOCURE LTD in Q1 2020. The put-call ratio across all filers is 1.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $344,000 | -47.6% | 2,963 | 0.0% | 0.01% | -42.1% |
| Q2 2021 | $657,000 | +67.6% | 2,963 | 0.0% | 0.02% | +58.3% |
| Q1 2021 | $392,000 | -23.6% | 2,963 | 0.0% | 0.01% | -25.0% |
| Q4 2020 | $513,000 | -74.6% | 2,963 | -83.7% | 0.02% | -78.4% |
| Q3 2020 | $2,023,000 | +87.7% | 18,177 | 0.0% | 0.07% | +76.2% |
| Q2 2020 | $1,078,000 | -35.4% | 18,177 | -26.7% | 0.04% | -46.2% |
| Q1 2020 | $1,670,000 | -10.5% | 24,806 | +12.0% | 0.08% | +25.8% |
| Q4 2019 | $1,866,000 | – | 22,144 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 470,884 | $27,923,000 | 10.09% |
| Darsana Capital Partners LP | 1,700,000 | $100,810,000 | 5.98% |
| HARTLINE INVESTMENT CORP/ | 336,617 | $19,961,000 | 4.18% |
| Rhenman & Partners Asset Management AB | 375,000 | $22,238,000 | 2.40% |
| MORGAN JESS S & CO INC | 35,942 | $2,131,000 | 2.31% |
| Soleus Capital Management, L.P. | 56,397 | $3,344,000 | 1.91% |
| Bullseye Asset Management LLC | 45,161 | $2,678,000 | 1.43% |
| Taylor Frigon Capital Management LLC | 46,304 | $2,746,000 | 1.36% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $593,000 | 1.09% |
| Redwood Investments, LLC | 192,986 | $11,444,000 | 1.01% |